Wave Life Sciences Ltd.WVENASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average, slight contraction.
Left:
||||
Year-over-year net income growth rate
Latest
-6.70%
↑ 76% above average
Average (39q)
-27.45%
Historical baseline
Range
High:147.35%
Low:-458.35%
CAGR
-4.7%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -6.70% |
| Q2 2025 | -7.66% |
| Q1 2025 | -260.25% |
| Q4 2024 | 147.35% |
| Q3 2024 | -87.65% |
| Q2 2024 | -4.33% |
| Q1 2024 | -94.13% |
| Q4 2023 | -324.16% |
| Q3 2023 | 134.36% |
| Q2 2023 | 22.99% |
| Q1 2023 | 37.30% |
| Q4 2022 | -12.06% |
| Q3 2022 | 5.55% |
| Q2 2022 | -9.21% |
| Q1 2022 | -8.71% |
| Q4 2021 | -458.35% |
| Q3 2021 | 83.93% |
| Q2 2021 | 8.71% |
| Q1 2021 | -47.50% |
| Q4 2020 | 13.02% |
| Q3 2020 | 18.33% |
| Q2 2020 | 14.67% |
| Q1 2020 | 16.34% |
| Q4 2019 | -11.91% |
| Q3 2019 | -20.94% |
| Q2 2019 | 5.11% |
| Q1 2019 | -16.66% |
| Q4 2018 | -0.68% |
| Q3 2018 | -4.84% |
| Q2 2018 | -1.85% |
| Q1 2018 | -16.65% |
| Q4 2017 | -15.60% |
| Q3 2017 | -5.84% |
| Q2 2017 | -17.61% |
| Q1 2017 | -13.77% |
| Q4 2016 | -5.24% |
| Q3 2016 | -51.62% |
| Q2 2016 | -47.38% |
| Q1 2016 | -10.54% |
| Q4 2015 | -43.82% |